ORBIMED ADVISORS LLC bought a fresh place in Chemomab Therapeutics Ltd. (NASDAQ:CMMB). The institutional investor bought 2.6 million shares of the stock in a transaction
Tag: DoorDash Inc.
RBC Capital Mkts raised the price target for the DoorDash Inc. (NYSE:DASH) stock to “an Outperform”. The rating was released on May 27, 2021. We